Good morning Wake-Up Watchlisters! While you’re sipping coffee you’ll see U.S. equity-index futures dropped on Friday. Contracts on the S&P 500 and Nasdaq 100 fell at least 0.8%, with indexes posting their biggest declines since Nov. 2 on Thursday. With the Federal Reserve recently announcing it will continue rate hikes into 2023, economists now see a 60% probability of recession next year.

With more potential pain ahead, we want to make sure you have the tools to weather economic downturns, which is why our Head Fundamental Tactician Karim Rahemtulla is talking about this $3 alternative investment. He’s also talking about why moving your money into this asset BEFORE Jan. 6, 2023 could be a good idea.

Click here to learn how you can protect your money in these markets.

Here’s a look at the top-moving stocks this morning.

Exact Sciences Corporation (Nasdaq: EXAS)

Exact Sciences Pharmaceuticals is up 13.18% premarket after Guardant tanked 40% due to poor results from a study using its blood test to screen for colorectal cancer. Overall, Exact Sciences’ stool-sample test is still the most effective, which was the main reason for the spike.

Biotech stocks have shown potential for massive gains throughout history. If you want to learn how we play this sector, we invite you to join us in The War Room. We have a 77% win rate in 2022 and right now we’re guaranteeing members receive 252 winning trades in their first 12 months.

Click here to unlock The War Room.

Maxar Technologies (NYSE: MAXR)

Maxar is up 115.37% premarket after it was announced the private equity company Advent would buy Maxar for about $4 billion. Including debt, the transaction is worth $6.4 billion. Advent will pay $53 a share for Maxar.

Rithm Capital Corp. (NYSE: RITM)

Rithm Capital Corp. is up 7.03% premarket after the software company announced its Board of Directors has declared fourth quarter 2022 common and preferred stock dividends. The board declared a quarterly dividend of $0.25 per share of common stock for the fourth quarter of 2022. The dividend is payable on January 27, 2023.

Avaya Holdings Corp. (NYSE: AVYA)

Avaya is down 28.73% premarket after approaching chapter 11 bankruptcy filing. The company had said there was substantial doubt about its ability to continue due to debt maturity concerns. As of now, it said it has been in talks with other financial stakeholders regarding a comprehensive resolution to its balance sheet.

If more economic pain persists in 2023, it’s important to consider a different way to invest

Gold and precious metal investing has been a proven way to combat inflation throughout history. And right now our friends at Stansberry Research are unveiling their ‘No. 1 Gold Play for 2022.’ It’s not an ETF or Mining Stock, it’s actually a virtually unknown investment. But it could pay you handsomely as gold soars higher.

Click here to learn more about ‘The No. 1 Gold Play for 2022.’

Those are the top market movers today.

Happy trading!

The Wake-Up Watchlist Research Team